BUY SBI Cards and Payment Services Limited — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))7 Sept 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
SBI Cards Gets Crisil ESG 71 Rating in Leadership Category
NewsGoogle News·9 Sept · 2w ago
SBI Cards ESG score rises to 80.2 in FY26 on environmental gains
NewsGoogle News·5 Sept · 2w ago
BIG DEAL | ICICI Prudential raises stake in SBI Cards and Payment Services to 7.30%
NewsLivemint·27 Aug · 4w ago
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·18 Aug · 1mo ago
SBI Cards concludes September 1 investor meet; discloses participant list
NewsGoogle News·1 Sept · 3w ago
SBI Cards holds one-on-one investor meet with State Street
NewsGoogle News·1 Sept · 3w ago
SBI Cards sets 28th AGM for Aug 31, 2026 with remote e-voting
NewsGoogle News·30 Aug · 3w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on SBI Cards and Payment Services
- SELL — Shrikant Chouhan, Kotak Securities23 Oct 2026 · ~2 weeks · target ₹500 · Active
- SELL — Rajesh Satpute15 Sept 2026 · ~2 weeks · target ₹620 · Target hit
- BUY — Deven Mehata, IDBI Capital Markets and Securities11 Sept 2026 · ~2 weeks · target ₹720 · SL hit
- BUY — Prakash Gaba8 Sept 2026 · Same day · target ₹680 · SL hit
- BUY — ICICI Securities8 Sept 2026 · ~2 weeks · target ₹703.9 · Expired
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · Active
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

